Inhalation Products

In inhalation drug development, SkyePharma offers:

Cost effective devices

• Metered Dose Inhalers (MDIs) 
• Dry Powder Inhalers (DPIs) 

Proprietary formulation technologies

SkyePharma uses a range of novel excipients in its formulation technologies to optimise dose-to-dose repeatability; a major hurdle for regulatory approval of inhalation products. 

For enquiries, please
contact us.

 

Copyright 2012, SkyePharma. All Rights Reserved.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom